A. A. Alonso

Medical therapy in patients with acromegaly: predictors of response and comparison of efficacy of dopamine agonists and somatostatin analogues.

R. Clayton, P. Stewart, R. Reulen, 2009, The Journal of clinical endocrinology and metabolism.

The modulation of corticosteroid metabolism by hydrocortisone therapy in patients with hypopituitarism increases tissue glucocorticoid exposure.

R. Murray, N. Crabtree, L. Behan, 2015, European journal of endocrinology.

ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly.

R. Clayton, P. Stewart, M. Sheppard, 2009, The Journal of clinical endocrinology and metabolism.

P940: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN WITH PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM-4 STUDY

Xiaoping Zhou, N. Callander, A. Oriol, 2022, HemaSphere.

The Adaptive, Pain Sensitive, and Global Symptoms Clusters: Evidence from a Patient-Based Study

D. Vivaldi, C. B. Meloto, F. Al-Hamed, 2023, JDR clinical and translational research.

Obesity, endothelial function and inflammation: the effects of weight loss after bariatric surgery

M. P. Paredes, A. A. Alonso, Manuel Ortega, 2016 .

ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly.

R. Reulen, J. Ayuk, M. Sherlock, 2009, The Journal of clinical endocrinology and metabolism.

Monitoring disease activity using GH and IGF‐I in the follow‐up of 501 patients with acromegaly

R. Clayton, R. Reulen, J. Ayuk, 2009, Clinical endocrinology.